HBM Healthcare Investments AG Financials

Market Capitalization CHF1.13 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	61.99
Forward PE	10.36
Price to Sales TTM	CHF50.66
Price to Book MRQ	CHF0.69
Enterprise to Revenue	55.92
Enterprise to EBITDA

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2025-03-31
Profit Margin	83.07%
Operating Margin	101.27%
Return on Assets TTM	0.70%
Return on Equity TTM	1.11%

Income Statement

Revenue TTM	CHF22,322,000
Revenue per Share TTM	CHF3.28
Quarterly Revenue Growth	-206.43%
Gross Profit TTM	CHF22,322,000
EBITDA	CHF0
Net Income to Common TTM	CHF18,542,000
Diluted EPS TTM	CHF2.72
Quarterly Earnings Growth YoY	-130.11%

Balance Sheet

Total Cash MRQ	CHF2,479,000
Total Cash per Share MRQ	CHF0.37
Total Debt MRQ	CHF
Total Debt to Equity MRQ	6.05
Current Ratio MRQ	0.81
Book Value per Share MRQ	CHF244.41

Cash Flow

Operating Cash Flow TTM	CHF-2,361,000
Levered Free Cash Flow TTM	CHF11,383,125

HBMN Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	6,732,380
Float Shares	None
Avg 10 Volume	6,070
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	16.82%
% Held by Institutions	4.11%

Stock Price Summary

Beta	0.84
Fifty Two Week Low	CHF150.00
Fifty Two Week High	CHF208.50
Fifty Two Week Change	-19.49%
Day 50 MA	CHF173.62
Day 200 MA	CHF181.78

Dividends and Splits

Forward Annual Dividend Rate	CHF30.00
Forward Annual Dividend Yield	17.88%
Trailing Annual Dividend Rate	CHF7.50
Trailing Annual Dividend Yield	4.47%
Payout Ratio	275.74%
Dividend Date	2024-08-09
Ex Dividend Date	2025-07-02
Last Split Factor
Last Split Date